ENTITY
Shandong Xinhua Pharmaceutical

Shandong Xinhua Pharmaceutical (719 HK)

114
Analysis
Health Care • China
Shandong Xinhua Pharmaceutical is a Chinese company specializing in the development, production, and distribution of chemical bulk drugs, pharmaceutical preparations, and medical intermediates. It is a leading global manufacturer and exporter of antipyretics and analgesics, as well as drugs for the central nervous system, steroids, and cardio cerebrovascular system. The company was established in 1943 and is headquartered in Zibo, Shandong, China.
more
•09 Aug 2026 01:16

Primer: Shandong Xinhua Pharm Co A (000756 CH) - Aug 2026

Shandong Xinhua is a leading Chinese producer of bulk active pharmaceutical ingredients (APIs), particularly in antipyretics and analgesics, but...

Logo
96 Views
Share
•05 Aug 2026 09:48

Primer: Shandong Xinhua Pharmaceutical (719 HK) - Aug 2026

Dominant API Manufacturer Facing Severe Margin Pressure: Shandong Xinhua is a global leader in Active Pharmaceutical Ingredients (APIs) for...

Logo
123 Views
Share
•27 Sep 2026 10:15

A-H Premium Weekly (Sep 25th): Innocare Pharma, Vgt, ABC, Yofc

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Innocare Pharma, Victory Giant Technology, ABC, Yofc.

Logo
96 Views
Share
•09 Aug 2026 10:15

A-H Premium Weekly (Aug 7th): Remegen, Cmoc, Shandong Gold Mining Co Lt-H, Luxshare Ict

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Remegen, Cmoc, Shandong Gold Mining Co Lt-H, Luxshare Ict,...

Logo
105 Views
Share
•11 Aug 2022 08:41

Will the Approval of Genuine Biotech's COVID-19 Oral Drug Change China's Zero-COVID Policy?

Due to VBP/fierce competition/weak demand, Azivudine's outlook is challenging.Until President Xi’s 3rd term appointment is confirmed,there’s no...

Logo
407 Views
Share
x